Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging

Wellens HJJ, Shwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, et al. Risk stratification for sudden cardiac death: Current status and challenges for the future. Eur Heart J. 2014;35:1642–51.CrossRefGoogle Scholar

Cohn JN, Levine BT, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J Med. 1984;311:819–23.CrossRefGoogle Scholar

Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993;22:72A–84A.CrossRefGoogle Scholar

Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.Google Scholar

Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study. J Am Coll Cardiol. 2003;41:231–8.CrossRefGoogle Scholar

Kioka H, Yamada T, Mine T, Morita T, Tsukamoto Y, Tamaki S, et al. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart. 2007;93:1213–8.CrossRefGoogle Scholar

Tamaki S, Yamada T, Okumura Y, Motita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol. 2009;53:426–35.CrossRefGoogle Scholar

Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial 123I-mIBG imaging and cardiac events in heart failure: Results of the prospective ADMIRE-HF study. J Am Coll Cardiol. 2010;55:2212–21.CrossRefGoogle Scholar

Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, et al. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol. 2011;107:1185–90.CrossRefGoogle Scholar

Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of ¹²³I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6:772–84.CrossRefGoogle Scholar

Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: Incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol. 2014;21:756–62.CrossRefGoogle Scholar

Kawai T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, et al. Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction < 35% at low risk of sudden cardiac death. Am J Cardiol. 2015;115:1549–54.CrossRefGoogle Scholar

Hakui H, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, et al. Usefulness of cardiac metaiodobenzylguanidine imaging to improve prognostic power of the model for end-stage liver disease scoring system in patients with mild-to-moderate chronic heart failure. Am J Cardiol. 2016;117:1947–52.CrossRefGoogle Scholar

Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV. Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake. J Nucl Cardiol. 2012;19:92–9.CrossRefGoogle Scholar

Dimitriu-Leen AC, Sholte AJHA, Jacobson AF. ¹²³I-MIBG SPECT for evaluation of patients with heart failure. J Nucl Med. 2015;56:25S–30S.CrossRefGoogle Scholar

Clements IP, Garcia EV, Chen J, Folks RD, Butler J, Jacobson AF. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99 m tetrofosmin myocardial perfusion SPECT. J Nucl Cardiol. 2016;23:425–35.CrossRefGoogle Scholar

Stanton MS, Zipes DP. Modulation of drug effects by regional sympathetic denervation and supersensitivity. Circulation. 1991;84:1709–14.CrossRefGoogle Scholar

Yamazaki J, Muto H, Ishiguro S, Okamoto K, Hosoi H, Nakano H, et al. Quantitative scintigraphic analysis of ¹²³I-MIBG by polar map in patients with dilated cardiomyopathy. Nucl Med Com. 1997;18:219–29.CrossRefGoogle Scholar

Fukuoka S, Hayashida K, Hirose Y, Shimotsu Y, Ishida Y, Kakuchi H, et al. Use of ¹²³I-MIBG myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy. Eur J Nucl Med. 1997;24:523–9.Google Scholar

Marini C, Giorgetti A, Gimelli A, Kusch A, Sereni N, Abbate AL, et al. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischemic heart disease or by dilated cardiomyopathy. Eur J Nucl Med Mol Imaging. 2005;32:682–8.CrossRefGoogle Scholar

McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med. 1971;285:1441–6.CrossRefGoogle Scholar

Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, et al. Prognostic significance of cardiac I-123 metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: A prospective study. Heart. 2001;86:656–60.CrossRefGoogle Scholar

Okuda K, Nakajima K, Hosoya T, Ishikawa T, Matsuo S, Kawano M, et al. Quantification of myocardial perfusion SPECT using freeware package (cardioBull). Ann Nucl Med. 2011;25:571–9.CrossRefGoogle Scholar

Witcher T, Hindricks G, Lerch H, Bartenstein P, Borgreffe M, Shober O, et al. Regional myocardial sympathetic denervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using ¹²³I-MIBG scintigraphy. Circualtion. 1994;89:667–83.CrossRefGoogle Scholar

Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004;95:754–63.CrossRefGoogle Scholar

Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, et al. ¹²³I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: A prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1:131–40.CrossRefGoogle Scholar

Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77.CrossRefGoogle Scholar

Marshall A, Cheetham A, George RS, Mason M, Kelion AD. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention. Heart. 2012;9:1359–65.CrossRefGoogle Scholar

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847.CrossRefGoogle Scholar

Pretorius H, Menke D, Richards N, Budke B. Modified fractal analysis of brain PET and SPECT defines three distinct cognitive groups in medical office patients: Near normal, mild cognitive impairment and early dementia. J Nucl Med. 2014;55:1851.Google Scholar